Prognostic Significance of Preoperative Controlling Nutritional Status (CONUT) Score in Patients Undergoing Hepatic Resection for Hepatocellular Carcinoma: A Multi-institutional Study

[1]  H. Baba,et al.  The Prognostic Impact of Controlling Nutritional Status (CONUT) in Intrahepatic Cholangiocarcinoma Following Curative Hepatectomy: A Retrospective Single Institution Study , 2018, World Journal of Surgery.

[2]  Y. Sakamoto,et al.  Controlling Nutritional Status (CONUT) score is a prognostic marker for gastric cancer patients after curative resection , 2018, Gastric Cancer.

[3]  Y. Maehara,et al.  Prognostic Significance of Preoperative Controlling Nutritional Status (CONUT) Score in Patients Undergoing Hepatic Resection for Hepatocellular Carcinoma , 2017, World Journal of Surgery.

[4]  Y. Maehara,et al.  Prognostic impact of controlling nutritional status score in resected lung squamous cell carcinoma. , 2017, Journal of thoracic disease.

[5]  Kazuhiko Yoshida,et al.  Preoperative controlling nutritional status (CONUT) score as a novel predictive biomarker of survival in patients with localized urothelial carcinoma of the upper urinary tract treated with radical nephroureterectomy. , 2017, Urologic oncology.

[6]  Tao Yang,et al.  The Prognostic Value of Tumor-infiltrating Lymphocytes in Hepatocellular Carcinoma: a Systematic Review and Meta-analysis , 2017, Scientific Reports.

[7]  G. Song,et al.  Pure Laparoscopic Versus Open Right Hepatectomy for Hepatocellular Carcinoma in Patients With Cirrhosis: A Propensity Score Matched Analysis , 2017, Annals of surgery.

[8]  T. Fujiwara,et al.  Preoperative Controlling Nutritional Status (CONUT) Score for Assessment of Prognosis Following Hepatectomy for Hepatocellular Carcinoma , 2017, World Journal of Surgery.

[9]  Kazuhiko Yoshida,et al.  PREOPERATIVE CONTROLLING NUTRITIONAL STATUS (CONUT) SCORE AS A NOVEL PREDICTIVE BIOMARKER OF SURVIVAL IN PATIENTS WITH LOCALIZED UROTHELIAL CARCINOMA OF THE UPPER URINARY TRACT TREATED WITH RADICAL NEPHROURETERECTOMY: MP78‐12 , 2017, Urologic oncology.

[10]  H. Ohdan,et al.  Glasgow Prognostic Score and Prognosis After Hepatectomy for Hepatocellular Carcinoma , 2017, World Journal of Surgery.

[11]  Y. Maehara,et al.  The Preoperative Controlling Nutritional Status Score Predicts Survival After Curative Surgery in Patients with Pathological Stage I Non-small Cell Lung Cancer. , 2017, Anticancer research.

[12]  Y. Maehara,et al.  Sarcopenia is a poor prognostic factor following hepatic resection in patients aged 70 years and older with hepatocellular carcinoma , 2016, Hepatology research : the official journal of the Japan Society of Hepatology.

[13]  V. Wong,et al.  Prognostic Nutritional Index (PNI) Predicts Tumor Recurrence of Very Early/Early Stage Hepatocellular Carcinoma After Surgical Resection , 2015, Annals of Surgical Oncology.

[14]  J. I. de Ulíbarri Pérez,et al.  Nutritional screening; control of clinical undernutrition with analytical parameters. , 2014, Nutricion hospitalaria.

[15]  T. Yamanaka,et al.  Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma , 2013, The British journal of surgery.

[16]  B. North,et al.  A novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: the prognostic nutritional index (PNI) , 2012, British Journal of Cancer.

[17]  Y. Maehara,et al.  Improvement of Long-Term Outcomes in Hepatitis C Virus Antibody–Positive Patients with Hepatocellular Carcinoma after Hepatectomy in the Modern Era , 2011, World Journal of Surgery.

[18]  M. Koch,et al.  Portal Triad Clamping Versus Vascular Exclusion for Vascular Control During Hepatic Resection: A Systematic Review and Meta-analysis , 2009, Journal of Gastrointestinal Surgery.

[19]  P. Allavena,et al.  Cancer-related inflammation , 2008, Nature.

[20]  Y. Maehara,et al.  Longterm favorable results of limited hepatic resections for patients with hepatocellular carcinoma: 20 years of experience. , 2007, Journal of the American College of Surgeons.

[21]  H. El‐Serag,et al.  Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. , 2007, Gastroenterology.

[22]  Y. Maehara,et al.  Trends in morbidity and mortality after hepatic resection for hepatocellular carcinoma: an institute's experience with 625 patients. , 2007, Journal of the American College of Surgeons.

[23]  A. Soran,et al.  Are pretreatment serum albumin and cholesterol levels prognostic tools in patients with colorectal carcinoma? , 2006, Medical science monitor : international medical journal of experimental and clinical research.

[24]  N. Demartines,et al.  Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of Surgery.

[25]  A. Burroughs,et al.  Hepatocellular carcinoma , 2003, The Lancet.

[26]  L. Coussens,et al.  Inflammation and cancer , 2002, Nature.

[27]  L. Caregaro,et al.  Nutrition and survival in patients with liver cirrhosis. , 2001, Nutrition.

[28]  K. Shirabe,et al.  Prognosis of recurrent hepatocellular carcinoma: a 10-year surgical experience in Japan. , 1996, Gastroenterology.

[29]  E. Oki,et al.  CONUT: a novel independent predictive score for colorectal cancer patients undergoing potentially curative resection , 2016, International Journal of Colorectal Disease.

[30]  J Ignacio de Ulíbarri,et al.  CONUT: a tool for controlling nutritional status. First validation in a hospital population. , 2005, Nutricion hospitalaria.

[31]  K. Shirabe,et al.  Results of 280 liver resections for hepatocellular carcinoma. , 1996, Archives of surgery.

[32]  D. Woodfield.  Hepatocellular carcinoma. , 1986, The New Zealand medical journal.